Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
International Society for Stem Cell Research Ms. Glori Rosenson Conference II ISSCR 2019 Nucleus Forum $24,000
University of California, San Francisco David H Rowitch Conference II “Myelin Through the Ages: Evolution, Development, Degeneration and Disease” – 2018 Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) $10,000
Keystone Symposia on Molecular and Cellular Biology Thale Jarvis Conference II iPSCs: A Decade of Progress and Beyond $35,000
Alliance Forum Foundation George Hara Conference II 2017 World Alliance Forum in San Francisco (WAFSF) “Healthcare Game Changers” $5,000
University of California, Irvine Dr. Leslie M Thompson Conference II Stem Cells for Huntington’s Disease (HD) International (SC4HDI) Conference $31,727
RUNX1 Research Program Timothy Babich Conference II Living with and Curing RUNX1 FPD/AML Forum $9,500
University of California, Los Angeles Song Li Conference II The 18th Annual UC System-Wide Bioengineering Symposium $25,000
JDRF International JDRF Esther Latres Conference II JDRF Encapsulation Consortium Fall 2017 Meeting $42,425
Stanford University Dr. Samuel Strober Conference II Third International Workshop on Clinical Tolerance $29,500
American Association of Blood Banks Dr. Naynesh R. Kamani Conference II 15th International Cord Blood Sympsium $30,000
Stanford University Dr. Joseph C. Wu Conference II 2017 Stanford Drug Discovery and Stem Cell Technology Conference $2,359
University of Southern California Dr. Justin K Ichida Conference II The 7th Annual California ALS research network and PAC10 meeting $10,830
Vitalant Research Institute Shibani Pati Conference II Cellular Therapies and Transfusion Medicine in Trauma and Critical Care – Looking Towards the Future $30,000
University of California, San Diego Dr. Robert Lie-Yuan Sah Conference II 2016 Tissue Engineering and Regenerative Medicine International Society – Americas (TERMIS-AM) Conference in San Diego, CA on December 11-14, 2016 $40,000
Midwinter Conference of Immunologists Dr. Christel H. Uittenbogaart Conference II The 2017 Midwinter Conference of Immunologists at Asilomar $5,000
Alliance Forum Foundation George Hara Conference II 2016 World Alliance Forum in San Francisco (WAFSF) “US-Japan Innovative Healthcare Technologies Conference” $20,000
University of California, Irvine Dr. LESLIE M Thompson Conference II HD-CARE INAUGURAL SYMPOSIUM $1,500
Keystone Symposia on Molecular and Cellular Biology Thale Jarvis Conference II Neurogenesis during Development and in the Adult Brain (joint with Transcriptional and Epigenetic Control in Stem Cells) $35,000
American Association of Blood Banks Dr. Naynesh R. Kamani Conference II 14th International Cord Blood Symposium: Give Life Twice $15,000
University of California, San Diego Prof. John M. Ravits Conference II California ALS Research Summit 2016 $11,400
Stanford University Dr. Joseph C. Wu Conference II Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference $7,500
Gordon Research Conferences Dr. Ophir Klein MD, PhD Conference II 2016 Gordon Research Conference on Craniofacial Morphogenesis and Tissue Regeneration $5,000
City of Hope, Beckman Research Institute Fouad Kandeel Conference II 2016 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium $10,000
International Society for Experimental Hematology Dr. David Traver Conference II International Society for Experimental Hematology, 45th Annual Scientific Meeting $25,000
University of California, Los Angeles Dr. Donald B. Kohn PhD Conference II Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop $29,807
Alliance Forum Foundation George Hara Conference II 2015 World Alliance Forum in San Francisco (2015 WAFSF) “Regenerative Medicine: Let’s Talk Business!” $10,000
Sanford Consortium for Regenerative Medicine Dr. Edward Holmes Conference II Stem Cell Meeting on the Mesa $50,000
University of California, Irvine Dr. Sidney Golub Conference II Human Research In Times of Controversy: From Stem Cells To Fetal Tissue $13,562
Neurona Therapeutics Dr. Cory R Nicholas Clinical Trial Stage Projects Inhibitory Interneuron Cell Therapy (NRTX-1001) for the Treatment of Drug-resistant Bilateral Temporal Lobe Epilepsy $13,999,983
University of California, San Francisco Mort Cowan Clinical Trial Stage Projects Gene Therapy for Artemis-Deficient Severe Combined Immunodeficiency Using a Self-Inactivating Lentiviral Vector $14,999,999
Tenaya Therapeutics, Inc. Dr. Matthew Pollman Clinical Trial Stage Projects Phase 1b Study of TN-401 in Adults with PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) $8,000,000
Tr1X Inc. Dr. Maria Grazia Roncarolo Clinical Trial Stage Projects TRX103 for prevention of GvHD in patients receiving HLA mismatched HSCT for the treatment of hematologic malignancies $8,000,000
University of California, Los Angeles Dr. Donald B. Kohn PhD Clinical Trial Stage Projects Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS-ADA lentiviral vector encoding for human ADA gene in ADA-SCID subjects $14,325,181
Fate Therapeutics, Inc. Bob Valamehr Clinical Trial Stage Projects A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus $7,934,448
Senti Biosciences, Inc. Rochelle Emery Clinical Trial Stage Projects Selective, Off-the-Shelf Logic Gated CAR NK Cell Therapy Targeting CD33 and/or FLT3 Expressing Hematologic Malignancies $8,000,000
ImmPACT-Bio, Inc. DR Jonathan Benjamin Clinical Trial Stage Projects A phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus $841,214
Nexcella, Inc. Ilya Rachman MD PhD Clinical Trial Stage Projects Autologous BCMA CAR-T Cells for the Treatment of Relapsed Refractory Light Chain Amyloidosis $7,999,467
University of California, San Francisco Dr. Hideho Okada Clinical Trial Stage Projects Phase 1 Study of Autologous E-SYNC T Cells in Adult Participants with EGFRvIII+ Glioblastoma $10,927,618
Aspen Neuroscience Dr. Edward Wirth III Clinical Trial Stage Projects Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease $8,000,000
Alto Neuroscience Amit Etkin Clinical Trial Stage Projects A Phase 2b Study of the Efficacy of a Novel Pro-Neurogenesis/Pro-Plasticity Drug for Bipolar Depression Using a Precision Psychiatry Approach $0
Allogene Therapeutics Dr. John Le Gall Clinical Trial Stage Projects A PHASE 1B STUDY EVALUATING THE SAFETY AND EFFICACY OF AN ALLOGENEIC CELL THERAPY IN SUBJECTS WITH CLEAR CELL RENAL CELL CARCINOMA (ccRCC) $15,000,000
University of California, San Francisco Noriyuki Kasahara Clinical Trial Stage Projects A Phase I/IIa Study to Evaluate the Efficacy of Toca 511/Toca FC with Standard of Care Therapy in Newly Diagnosed High Grade Glioma $11,807,220
Luxa Biotechnology Dr. Jeffrey H Stern Clinical Trial Stage Projects RPESC-RPE-4W Therapy for dry Age-related Macular Degeneration $4,009,675
Rocket Pharmaceuticals, Inc. Dr. Jonathan Schwartz Clinical Trial Stage Projects A Phase 2 Study Evaluating the Efficacy and Safety of IV Administered rAAV9 Vector Containing RP-A501 in Male Patients with Danon Disease $5,808,735
University of California, Davis Dr. Diana L. Farmer Clinical Trial Stage Projects The CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele $8,996,477
Stanford University Dr. Reena Parada Thomas Clinical Trial Stage Projects Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme $11,999,991
City of Hope, Beckman Research Institute Elizabeth Budde Clinical Trial Stage Projects Phase I Study of Chimeric Antigen Receptor Engineered T Cells targeting CD33 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia $11,983,547
University of California, San Diego Prof. Olivia Kim-McManus Clinical Trial Stage Projects Personalized antisense oligonucleotide therapy for rare pediatric genetic disease: SCN2A $960,713
Stanford University Anusha Kalbasi Clinical Trial Stage Projects Stem-Derived IL13Ra2 Chimeric Antigen Receptor T cells for Patients with Melanoma and Advanced Solid Tumors $10,211,085
University of California, Los Angeles Dr. Jeffrey L Veale Clinical Trial Stage Projects The UCLA Delayed Immunological Tolerance after Kidney Transplantation Program $6,717,608
1 … 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 … 31

How to Apply

Learn More

Explore CIRM-Funded Clinical Trials

Learn More

Managing Your Grant

Learn More

See our Active Awards Portfolio

Learn More